Jun 22, 2020
OncoSec Presents Two Late-Breaking Abstracts on TAVO-PLUS at the American Association for Cancer Research (AACR) Virtual Annual Meeting II
Jun 11, 2020
Partner Therapeutics Announces Initiation of Clinical Trial Evaluating Leukine® in T Cell Replete HLA-mismatched Haploidentical Stem Cell Transplant
Jun 04, 2020
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum
Jun 02, 2020
World Markets for Interferons, 2030 (COVID-19 Adjusted) - Roche, Merck, BMS, Biogen, Bayer, Zydus Cadila, Novartis, Pfizer, Biosidus, and Nanogen are the Major Players
May 28, 2020
Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine® in Respiratory Illness in Patients with COVID-19 at Singapore General Hospital
May 27, 2020
Rebif® U.S. Label Now Includes Pregnancy Outcomes and Lactation Information to Help Inform Treatment Decisions for Women with MS
May 25, 2020
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum
May 19, 2020
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board
May 12, 2020
New Study: Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19
May 11, 2020
BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group
May 05, 2020
Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune(TM)
Apr 30, 2020
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
Apr 21, 2020
Multiple Sclerosis Drugs Industry Assessment 2020: Immunomodulators, Immunosuppressants, Interferons and Others
Apr 15, 2020
Roivant Doses First Patient in Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19 Patients for the Prevention and Treatment of Acute Respiratory Distress Syndrome
Apr 01, 2020
Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic
Apr 01, 2020
Salimetrics' Growing List of Cytokines Which Can Be Reliably Tested in Saliva Now Includes IL-17A, IL-5, and IL-7 for Fast, Easy Salivary Biomarker Analysis
Mar 24, 2020
Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine® in Patients with COVID-19 Associated Respiratory Illness
Mar 18, 2020
Roivant Announces Development of Anti-GM-CSF Monoclonal Antibody to Prevent and Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Mar 12, 2020
C-X-C Chemokine Receptor (CXCR) Inhibitors Market & Pipeline Insights, 2020 - Key Emerging Drugs (X4 Pharmaceutical's X4P-001 and Others) are Going to Be Blockbusters in the Coming Years
Jan 20, 2020
ZyVersa Therapeutics Releases Video Demonstrating How Inflammasomes Stimulate and Perpetuate Inflammation, and How a Novel Inflammasome Inhibitor, IC 100, Has Potential to Control Chronic Damaging Inflammation Associated with Inflammatory Diseases